Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myasthenia Gravis × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 233 Breast Neoplasms 127 Neoplasms 102 Prostatic Neoplasms 35 Fatigue 34 Obesity 24 Colorectal Neoplasms 22 Lung Neoplasms 20 Polycystic Ovary Syndrome 17 Colonic Neoplasms 15 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Pancreatic Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Stomach Neoplasms 6 Cognitive Dysfunction 6 Cachexia 6 Brain Neoplasms 6 Peripheral Nervous System Diseases 5 Overweight 5

Interventions

Rituximab 7 Pyridostigmine Bromide 5 Prednisone 5 efgartigimod alfa 4 Hizentra 4 telitacicept 3 Immunoglobulins, Intravenous 3 Cyclophosphamide 3 Azathioprine 3 thymoglobulin 2 fludarabine 2 Thymectomy 2 Steroids 2 Mycophenolic Acid 2 Data Collection 2 Blood Specimen Collection 2 zilucoplan 1 tofacitinib 1 tocilizumab 1 talquetamab 1 sargramostim 1 prednylidene 1 gamma-Globulins 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 bu-zhong-yi-qi-tang 1 apraclonidine 1 Walk Test 1 Telemedicine 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05992025 2025-03-30

DIG-MG

Uppsala University

Phase NA Completed

Fatigue, Motor Activity, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡